Activities per year
Activities
- 13 results
Search results
-
Årsmøde og overrækkelse af Hagedorn Prisen 2017
Tarec El-Galaly (Lecturer)
31 Mar 2017Activity: Talks and presentations › Talks and presentations in private or public companies
File -
Imaging in Lymphomas
Tarec El-Galaly (Lecturer)
14 Jul 2015Activity: Talks and presentations › Talks and presentations in private or public companies
File -
VALIDATION OF THE GERMAN HIGH-GRADE NON-HODGKIN LYMPHOMA STUDY GROUP (DSHNHL) PROGNOSTIC MODEL FOR CNS RELAPSE IN A LARGE COHORT OF PET/CT STAGED PATIENTS
Tarec El-Galaly (Lecturer)
17 Jun 2015 → 20 Jun 2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
Routine imaging for diffuse large B-cell lymphoma in first remission is not associated with better survival: A Danish-Swedish population-based study
Tarec El-Galaly (Lecturer)
17 Jun 2015 → 20 Jun 2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
Routine imaging does not improve post-remission survival for DLBCL in 1st remission - A Danish-Swedish population-based study
Tarec El-Galaly (Lecturer)
14 Mar 2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
Ny teknologi – bidrager den altid til overlevelse? Kan den komme til det, når vi har forstået hvad det kan? Hvornår er ny teknologi innovation og hvornår er det ”bare spændende”? Hvordan påvirker diagnostisk metode det tværfaglige samarbejde?
Tarec El-Galaly (Speaker)
2 Oct 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
A possible survival advantage in relapsed aggressive lymphoma, if detected by routine imaging; a review of 309 patients
Tarec El-Galaly (Lecturer)
7 Nov 2013Activity: Talks and presentations › Talks and presentations in private or public companies
-
Værdien af rutine billeddiagnostik under opfølgning af Hodgkin og aggressive non-Hodgkin lymfomer i første remission
Tarec El-Galaly (Lecturer)
6 Jun 2013Activity: Talks and presentations › Talks and presentations in private or public companies
-
Routine bone marrow biopsy has little or no therapeutic consequence for PET/CT staged Hodgkin lymphoma patients
Tarec El-Galaly (Lecturer)
1 Nov 2012 → 2 Nov 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Single Nucleotide Polymorphisms and Risk of Venous Thromboembolism
Tarec El-Galaly (Lecturer)
17 Jun 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
DLG-møde
Tarec El-Galaly (Speaker)
14 May 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
FOLLOW UP WITH 18-FDG PET/CT IN AGGRESSIVE LYMPHOMAS IN FIRST PET-NEGATIVE COMPLETE REMISSION
Tarec El-Galaly (Lecturer)
20 Mar 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Ekstranodale lymfomer: - et klinisk perspektiv
Tarec El-Galaly (Lecturer)
24 Apr 2009Activity: Talks and presentations › Talks and presentations in private or public companies